The neuroprotective effect of FGFC1 was first demonstrated by Akamatsu et al., who showed that FGFC1 could reduce ischemic neuronal damage by inhibiting the OS response and matrix metalloproteinase-9 (MMP-9) activation in a mouse model of ischemic stroke [15]. This evidence concerns the gene MMP9 and ischemic stroke.